These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21107098)

  • 1. Phenotypic alterations in myoepithelial cells of the breast in normal and pathologic conditions.
    Pusztaszeri M
    Am J Surg Pathol; 2010 Dec; 34(12):1886; author reply 1886-7. PubMed ID: 21107098
    [No Abstract]   [Full Text] [Related]  

  • 2. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
    Tramm T; Kim JY; Tavassoli FA
    Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications.
    Hilson JB; Schnitt SJ; Collins LC
    Am J Surg Pathol; 2009 Feb; 33(2):227-32. PubMed ID: 18936688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma.
    Rabban JT; Chen YY
    Hum Pathol; 2008 Feb; 39(2):175-83. PubMed ID: 18206495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast.
    Hilson JB; Schnitt SJ; Collins LC
    Am J Surg Pathol; 2010 Jun; 34(6):896-900. PubMed ID: 20463570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial displacement into the lymphovascular space can be seen in breast core needle biopsy specimens.
    Koo JS; Jung WH; Kim H
    Am J Clin Pathol; 2010 May; 133(5):781-7. PubMed ID: 20395526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D2-40: an additional marker for myoepithelial cells of breast and the precaution in interpreting tumor lymphovascular invasion.
    Ren S; Abuel-Haija M; Khurana JS; Zhang X
    Int J Clin Exp Pathol; 2011 Jan; 4(2):175-82. PubMed ID: 21326813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal cell-specific and hyperproliferation-related keratins in human breast cancer.
    Wetzels RH; Kuijpers HJ; Lane EB; Leigh IM; Troyanovsky SM; Holland R; van Haelst UJ; Ramaekers FC
    Am J Pathol; 1991 Mar; 138(3):751-63. PubMed ID: 1705754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual usages of single Wilms' tumor 1 immunohistochemistry in evaluation of breast tumors: a preliminary study of 30 cases.
    Li JH; Man YG
    Cancer Biomark; 2009; 5(3):109-16. PubMed ID: 19407365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel myoepithelial/progenitor cell marker in the breast?
    Kolar Z; Ehrmann J; Turashvili G; Bouchal J; Mokry J
    Virchows Arch; 2007 May; 450(5):607-9. PubMed ID: 17429688
    [No Abstract]   [Full Text] [Related]  

  • 11. Massive myoepithelial proliferation (myoepitheliosis) with lumpy deposits of basement membrane material closely associated with apocrine adenosis and ductal carcinoma in situ of the breast.
    Kawasaki T; Oyama T; Nakagomi H; Furuya K; Kondo T; Nakazawa T; Mochizuki K; Yamane T; Miyazawa T; Ishii Y; Fukushima K; Moriya T; Tsunoda H; Katoh R
    Pathol Int; 2011 Oct; 61(10):615-7. PubMed ID: 21951673
    [No Abstract]   [Full Text] [Related]  

  • 12. Loss of myoepithelium is variable in solid papillary carcinoma of the breast.
    Nicolas MM; Wu Y; Middleton LP; Gilcrease MZ
    Histopathology; 2007 Nov; 51(5):657-65. PubMed ID: 17927587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
    Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DCIS and LCIS with multinucleated giant cells-a report of 4 cases.
    Coyne JD
    Histopathology; 2007 Apr; 50(5):669-71. PubMed ID: 17394507
    [No Abstract]   [Full Text] [Related]  

  • 15. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
    Hildenbrand R; Schaaf A
    Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of disease: breast tumor pathogenesis and the role of the myoepithelial cell.
    Barsky SH; Karlin NJ
    Nat Clin Pract Oncol; 2006 Mar; 3(3):138-51. PubMed ID: 16520804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sarcomatoid breast tumors have sarcomatoid behavior.
    Gilcrease MZ
    Am J Surg Pathol; 2007 Feb; 31(2):326-7; author reply 327. PubMed ID: 17255781
    [No Abstract]   [Full Text] [Related]  

  • 18. Best practices in diagnostic immunohistochemistry: myoepithelial markers in breast pathology.
    Dewar R; Fadare O; Gilmore H; Gown AM
    Arch Pathol Lab Med; 2011 Apr; 135(4):422-9. PubMed ID: 21466356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of two score systems in Bcl-2 and Bax protein expression in invasive ductal carcinoma of breast and relation with oestrogen and progestrone receptors.
    Ayatollahi H; Ghaffarzadegan K; Sharifi N; Farahmand MJ; Jarafian AH
    Breast J; 2009; 15(3):310-2. PubMed ID: 19645793
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies targeting p63 react specifically in the cytoplasm of breast epithelial cells exhibiting secretory differentiation.
    Bratthauer GL; Saenger JS; Strauss BL
    Histopathology; 2005 Dec; 47(6):611-6. PubMed ID: 16324199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.